Case Report: Novel mutations in TBC1D24 are associated with autosomal dominant tonic-clonic and myoclonic epilepsy and recessive Parkinsonism, psychosis, and intellectual disability
Mutations disrupting presynaptic protein TBC1D24 are associated with a variable neurological phenotype, including DOORS syndrome, myoclonic epilepsy, early-infantile epileptic encephalopathy, and non-syndromic hearing loss. In this report, we describe a family segregating autosomal dominant epilepsy...
Saved in:
Published in | F1000 research Vol. 6; p. 553 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Faculty of 1000 Ltd
2017
F1000Research F1000 Research Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 2046-1402 2046-1402 |
DOI | 10.12688/f1000research.10588.1 |
Cover
Summary: | Mutations disrupting presynaptic
protein TBC1D24 are associated with a variable neurological phenotype, including DOORS syndrome, myoclonic epilepsy, early-infantile epileptic encephalopathy, and non-syndromic hearing loss. In this report, we describe a family segregating autosomal dominant epilepsy, and a 37-year-old Caucasian female with a severe neurological phenotype including epilepsy, Parkinsonism, psychosis, visual and auditory hallucinations, gait ataxia and intellectual disability. Whole exome sequencing revealed two missense mutations in the
TBC1D24
gene segregating within this family (c.1078C>T; p.Arg360Cys and c.404C>T; p.Pro135Leu). The female proband who presents with a severe neurological phenotype carries both of these mutations in a compound heterozygous state. The p.Pro135Leu variant, however, is present in the proband’s mother and sibling as well, and is consistent with an autosomal dominant pattern linked to tonic-clonic and myoclonic epilepsy. In conclusion, we describe a single family in which
TBC1D24
mutations cause expanded dominant and recessive phenotypes. In addition, we discuss and highlight that some variants in
TBC1D24
might cause a dominant susceptibility to epilepsy |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing interests: No competing interests were disclosed. EB, IS and MK prepared the first draft of the manuscript. KR, NB, PMC and VN contributed towards the clinical summary, discussion and assessed the patient. SS, ALS, CB, AMC performed the sequencing, and MR, RR, MDB, IP, and MN performed bioinformatics analysis. KR, NB, SS, ALS, MR, RR, MDB, CB, IP, MN, AMC, SR, DWG, MJH, IS and VN contributed to the experimental design. All authors provided expertise in genomics and were involved in the revision of the draft manuscript and have agreed to the final content. |
ISSN: | 2046-1402 2046-1402 |
DOI: | 10.12688/f1000research.10588.1 |